Post-transplantation diabetes mellitus in patients with kidney allotransplantation
- Autores: Novikova M.S1, Allazova S.S2, Kotenko O.N3,4, Shilov E.M2
-
Afiliações:
- SBHCI "Endocrinological Dispensary of the Moscow Healthcare Department"
- FSAEI HE "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation
- SBHCI "City Clinical Hospital № 52 of the Moscow Healthcare Department DZM"
- FSAEI HE "Peoples' Friendship University of Russia"
- Edição: Nº 4 (2018)
- Páginas: 20-24
- Seção: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/272800
- DOI: https://doi.org/10.18565/nephrology.2018.4.20-24
- ID: 272800
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
M. Novikova
SBHCI "Endocrinological Dispensary of the Moscow Healthcare Department"
Email: citrus7474@mail.ru
PhD in Medical Sciences, Nephrologist
S. Allazova
FSAEI HE "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation
Email: tallisasoto@rambler.ru
Postgraduate Student at the Department of Internal, Occupational Diseases and Rheumatology
O. Kotenko
SBHCI "City Clinical Hospital № 52 of the Moscow Healthcare Department DZM"; FSAEI HE "Peoples' Friendship University of Russia"
Email: info@gkb52.mosgorzdrav.ru
PhD in Medical Sciences, Chief Freelance Specialist-Nephrologist of the Moscow Healthcare Department, Deputy Chief Physician for Nephrological Care; Associate Professor at the Department of Hospital Therapy with a Course of Hematology
E. Shilov
FSAEI HE "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation
Email: emshilov@mma.ru
Doctor of Medical Sciences, Professor at the Department of Internal, Occupational Diseases and Rheumatology
Bibliografia
- Данович Г.М. Трансплантация почки. Пер. с англ. под ред. Я.Г. Мойсюка. М., 2014. C. 227-260.
- Davidson J., Wilkinson A., Dantal J. New-onset diabetes after transplantation 2003. International Consensus Guidelines. Diab. Care. 2004;27(3):805-812.
- Ghisdal L., Van Laecke S., Abramowicz M.J., et al. New-onset diabetes after renal transplantation: risk assessment and management. Diab. Care. 2012;35(1):181-188.
- Vincenti F., Friman S., Scheuermann E., et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 2007;7(6):1506-1514.
- Woodward R.S., Schnitzler M.A., Baty J., et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am. J. Transplant. 2003;3:590-598.
- Burroughs T.E., Swindle J., Takemoto S., et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 2007;83(8):1027-34.
- Hjelmesaeth J., Hartmann A., Leivestad T., et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int. 2006;69:588-595.
- Kasiske B.L., Snyder J.J., Gilbertson D., Matas A.J. Diabetes mellitus after kidney transplantation in the United States. Am. J. Transplant. 2003; 3(2):178-185.
- Дедов И.И., Шестакова М.В., Галстян Г.Р. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (7-й выпуск). Сахарный диабет. 2015;18(1):7-9.
- Cosio F.G., Pesavento T.E., Osei K., et al. Posttransplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59(2):732-737.
- Heit J.J., Apelqvist A.A., Gu X., et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature. 2006;443:345-349.
- Tamura K., Fujimura T., Tsutsumi T., et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation. 1995;59:1606-1613.
- Ozbay L.A., Smidt K., Mortensen D.M., et al. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E ß-cells. Br. J. Pharmacol. 2011;162(1):136-146.
- Polastri L., Galbiati F., Bertuzzi F., et al. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol. 2002;39:229-233.
- Duijnhoven E.M., Boots J.M., Christiaans M.H., et al. Influence of tacrolimus on glucose metabolism before and after transplantation: a prospective study. J. Am. Soc. Nephrol. 2001;12:583-588.
- Fernandez L.A., Lehmann R., Luzi L., et al. The effects of maintenance doses of FK506 versus Cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation. 1999;6:1532-1541.
- Maffi P., Bertuzzi F., De Taddeo F., et al. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progressive of diabetic nephropathy. Diab. Care. 2007;30:1150-1155.
- Neumayer H.H., Farber L., Haller P., et al. Substitution of conventional cyclosporine with a new microemusion formulation in renal transplant patients: result after 1 year. Nephrol. Dial. Transplant. 1996;11:165-172.
- Mathew J.T., Rao M., Job V., et al. Post-transplant hyperglycaemia: a study of risk factors. Nephrol. Dial. Transplant. 2003;18:164-171.
- Cotovio P., Neves M., Rodrigues L., et al. New-onset diabetes after transplantations: assessment of risk factors and clinical outcomes. Transplant. Proc. 2013;45:1079-1083.
- Davidson J.A., Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist’s view. Diab. Care. 2004;27:805-812.
- Heisel O., Heisel R., Balshaw R., Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am. J. Transplant. 2004;4(4):583-595.
- Webster A.C., Woodroffe R.C., Taylor R.S., et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: metaanalysis and meta-regression of randomised trial data. Br. Med. J. 2005; 331(7520):810.
- Maes B.D., Kuypers D., Messiaen T., et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation. 2001;72(10):1655-1661.
- Ekberg H., Tedesco-Silva H., Demirbas A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 2007;357(25):2562-2575.
- Cai T.H., Esterl R.M., Nichols F., et al. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. Transplant. Proc. 1998;30(4):1413-1414.
- Luan F.L., Zhang H., Schaubel D.E., et al. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am. J. Transplant. 2008;8:1871-1877.
- Holm A., Hernandez M. A post-hoc analysis of the safety and efficacy of tacrolimus (Prograf) versus a “generic formulation” of tacrolimus (tenacrine) as primary immunosuppressive therapy in LRD and CAD, adults and pediatric renal transplant recipients. Transplantation. 2008;86(2):528.
- Meiser B.M., Uberfuhr P., Fuchs A., et al. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J. Heart Lung Transplant. 1998;17(8):782-788.
- Midtvedt K., Hjemesæth J., Hartmann A., et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J. Am. Soc. Nephrol. 2004;15(12):3233-3239.
- Tillmann F.P., Schmitz M., Rump L.C., Quack I. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-termfollow-up. Int. Urol. Nephrol. 2018;50(4):771-777. doi: 10.1007/s11255-017-1754-0.
- Luan F.L., Steffick D.E., Ojo A.O. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation. 2011;91(3):334-344.
- Hjelmesaeth J, Hartmann A, Kofstad J, et al. Tapering off prenisolone and cyclosporine the first year after renal transplantation: the effect on glucose tolerance. Nephrol. Dial. Transplant. 2001;16:829-835.
- Hjelmesaeth J., Hartmann A., Kofstad J., et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997;64(7):979-983.
- Knight S.R., Morris P.J. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A Meta-Analysis. Transplantation. 2010;89:1-14.